Stock comparison
AMGNvsINSM
Amgen IncvsInsmed Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
AMGN
Amgen Inc
$348.62
+6.70%
Biotechnology$188.8BNASDAQ
INSM
Insmed Inc
$144.48
-26.63%
Biotechnology$35.0BNASDAQ
60-day price, rebased to 100
AMGN +1.97% · INSM -8.45%
Round-by-round
AMGN 5·INSM 1
EdgeAMGN
Valuation upside
-41.60% vs -90.50% to DCF fair value
EdgeINSM
Balance-sheet strength
Altman Z 1.78 vs 9.81
EdgeAMGN
Fundamental quality
Piotroski 8.00 vs 4.00 (of 9)
EdgeAMGN
Growth + margins
Rule-of-40 32.00 vs -92.80
EdgeAMGN
60-day momentum
+1.97% vs -8.45% price return
EdgeAMGN
Market-cap liquidity
$188.8B vs $35.0B
Verdict
Across6categories,AMGNtakes the edge with5wins to1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onAMGNorINSM
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.